Sign in

CIK 0001711754

  • Non-accelerated filer
  • Smaller reporting company

Inmune Bio, Inc.

Sign in to watch
Ticker
INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
475205835
Phone
+1 858-964-3720
Business address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
  1. 4/A Other acquisition 10% owner acquired 192,533 shares (other)
  2. 4 Option exercise 10% owner acquired 108,000 shares (option exercise)
  3. 4/A Other acquisition 10% owner acquired 192,533 shares (other)
  4. 4 Option exercise President and CEO acquired 30,000 shares (option exercise)
  5. 4 Option exercise CFO, Treasurer & Secretary acquired 25,000 shares (option exercise)
  6. 4 Open-market sale Director sold 14,480 shares at $27.63 ($400,082)
  7. 4 Open-market sale Director sold 30,000 shares at $23.21 ($696,150)
  8. 4 Open-market sale Chief Scientific Officer sold 30,000 shares at an average $20.16 ($604,706)
  9. 4 Open-market sale CFO, Treasurer & Secretary sold 25,000 shares at an average $20.06 ($501,523)
  10. 4 Open-market sale President and CEO sold 30,000 shares at an average $20.07 ($602,050)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Director sold 10,000 shares at $19.02 ($190,200)
  19. 4 Other acquisition 10% owner acquired 192,532 shares (other)
  20. 4 Open-market sale Director sold 10,000 shares at $17.01 ($170,054)

Page 5 of 8 · 142 filings